Although heat-shock factor (HSF) 1 is a known transcriptional factor of heat-shock proteins, other pathways like production of aneuploidy and increased protein stability of cyclin B1 have been proposed. In the present study, the regulatory domain of HSF1 (amino-acid sequence 212-380) was found to interact directly with the amino-acid sequence 106-171 of Cdc20. The association between HSF1 and Cdc20 inhibited the interaction between Cdc27 and Cdc20, the phosphorylation of Cdc27 and the ubiquitination activity of anaphase-promoting complex (APC). The overexpression of HSF1 inhibited mitotic exit and the degradations of cyclin B1 and securin, which resulted in production of aneuploidy and multinucleated cells, but regulatory domain-deficient HSF1 did not. Moreover, HSF1-overexpressing cells showed elevated levels of micronuclei and genomic alteration. The depletion of HSF1 from cells highly expressing HSF1 reduced nocodazole-mediated aneuploidy in cells. These findings suggest a novel function of HSF1 frequently overexpressed in cancer cells, to inhibit APC/C activity by interacting with Cdc20, and to result in aneuploidy development and genomic instability.
Introduction
Aneuploidy, which is defined as an abnormal number of chromosomes or chromosome segments, is a ubiquitous feature of solid human tumors, and causes genetic instability and promotes further aneuploidy (Hida and Klagsbrun, 2005) . The majority of cancer cells are highly aneuploid, however, the molecular mechanisms underlying the development of aneuploidy have not been fully defined, although mutations in mitotic checkpoint genes have been identified in a subset of human cancers and cell lines (Lengauer et al., 1997; Cahill et al., 1998) .
Enhanced heat-shock protein (HSP) expression in response to various stimuli is regulated by heat-shock factors (HSFs), the functional relevance of which is now emerging. HSF1 (an HSF prototype) and HSF3 are responsible for heat-induced HSP expression, whereas HSF2 is refractory to classical stressors, and HSF4 is expressed in a tissue-specific manner (Pirkkala et al., 2001) . Homology between the amino-acid sequences of human HSFs is only 30-40%, and evidence for specific functions of HSFs beyond heat-shock response is speculative. Many types of tumors contain high concentrations of HSPs of the HSP27, HSP70 and HSP90 families (Hoang et al., 2000; Cen et al., 2004) . The roles of HSPs in tumor development may also be related to their functions in the development of tolerance to applied stress (Li and Werb, 1982) . However, the precise relationships between HSFs and HSPs during cancer development have not been clearly defined and relatively few papers about the role of HSF1 in cancer or carcinogenesis are available (Cen et al., 2004; Wang et al., 2004; Min et al., 2007) .
In this study, we identified a novel function of HSF1 with respect to inhibition of mitotic exit results in genomic instability and the development of aneuploidy and chromosomal missegregation, which it achieves by interacting directly with Cdc20 and thus inhibiting anaphase-promoting complex (APC) activity. Moreover, these phenomena were found to be independent of HSP induction, for example, of HSP25 and HSP70.
Results

HSF1 binds directly to Cdc20
Because HSF1-transfected radiation-induced fibrosarcoma (RIF) cells showed large numbers of aneuploid cells and mitotic arrest after radiation or heat-shock (data not shown), we examined whether HSF1 affect cell cycle proteins that have the potential to regulate mitosis. Immunoprecipitation (IP) analysis of HSF1 with several mitotic regulators such as Cdc20, Cdc27 and Cdc26 and so on revealed that HSF1 interacted with Cdc20 in HSF1-overexpressing cells, while HSP25 did not ( Figure 1a ). An in vitro translation assay also indicated direct binding between HSF1 and Cdc20 (Figure 1b) . When the interaction between HSF1 and Cdh1, another APC partner in mitotic progression was examined, no interaction was observed, suggesting a specific interaction between HSF1 and Cdc20 (Supplementary Figure 1A) . To elucidate whether other HSFs like HSF2 and 4 can also bind to Cdc20, IP was performed after transfection of HSF1, 2 or 4. It was found that only HSF1 bound Cdc20. Moreover, when we transfected Cdc20 to human osteogenic sarcoma (HOS) cells that show high levels of HSF1, 2 and 4, same result was obtained (Supplementary Figure 1B ). Deletion mutants of amino acids 1-212 of HSF1 (the N terminus of HSF1, HSF1DN) and of 380-503 of HSF1 (the C-terminal region, HSF1DC) interacted with Cdc20, but deletion mutant of amino acids 212-380 of the HSF1 regulatory domain (HSF1DReg) did not, as revealed by co-IP and immunoblotting (Figure 1c) . Moreover, the F2 deletion mutant of Cdc20 (Cdc20DF2) did not interact with HSF1, whereas the amino acids 1-171 (F1) and 108-171 (F2) bound directly to HSF1 (Figure 1d ). These data indicate that the interaction sites of HSF1 and Cdc20 are the regulatory domain of HSF1 and the F2 domain of Cdc20.
The interaction between HSF1 and Cdc20 inhibits APCCdc20 binding and APC activity The affinity of APC for activators is regulated by the phosphorylations of APC subunits (that is, APC1, 
GST-Cdc20F2 GST GST-Cdc20 F1 HSF1-induced mitotic exit failure and genomic instability YJ Lee et al Cdc27, Cdc16 and Cdc23) (Cross, 2003) . To elucidate whether HSF1-Cdc20 binding affects the Cdc20-APC interaction and the phosphorylations of APC subunits, HSF1 or HSP25 proteins were added to lysates of nocodazole-treated cells. As shown in Figure 2a (left), the interaction between Cdc20 and Cdc27, augmented by nocodazole treatment over a 16 h period, was reduced when HSF1 protein was added to the initial mix, but not when HSP25 protein was added, suggesting that HSF1 directly inhibited the interaction between Cdc20 and Cdc27 during mitosis. IP analysis also revealed that Cdc20-Cdc27 binding was diminished after nocodazole treatment in HSF1-overexpressing cells. However, control vector-transfected cells showed a higher level of Cdc20-Cdc27 interaction after release from nocodazole block and increased phosphorylation of Cdc27 was reduced by HSF1 transfection (Figure 2a , right). We next examined whether HSF1 affects the ubiquitination activity of APC by associating with Cdc20. The ubiquitin ligase activity of APC in mitotic HSF1-induced mitotic exit failure and genomic instability YJ Lee et al RIF cells was activated by incubating with in vitro translated Cdc20 protein and greatly inhibited by HSF1 protein, but not by HSP25 protein (Figure 2b ). We then reconstituted an APC-mediated ubiquitination assay in vitro and directly tested the ability of cyclin B1 ubiquitination to serve as a substrate for APC. The effect of HSF1 on APC/Cdc20 complex in vivo was examined by measuring the extent of cyclin B1 ubiquitination during mitosis in cells expressing hemagglutinin (HA)-HSF1 and HA-ubiquitin. HSF1 was found to be sufficient to inhibit cyclin B1 ubiquitination. However, when the cells expressing HA-HSF1DReg, instead of HA-HSF1 was used, cyclin B1 ubiquitination was not inhibited, even slightly increased (Figure 2c ), suggesting that binding HSF1 with Cdc20 affected APC activity.
Inhibition of mitotic exit by HSF1 overexpression
Analysis of cell cycle distributions revealed that more HSF1-transfected cells were in the G 2 /M phase than control vector-transfected cells from 6 h after release from thymidine block (Figure 3a , left). When histone H3 phosphorylation was monitored as a mitosis marker after nocodazole treatment, HSF1 was found to dramatically prolong histone H3 phosphorylation. Moreover, the peak percentage of phosphorylated histone H3 was similar in both control and HSF1-transfected cells, but this phosphorylation was more prolonged in HSF1-transfected cells (Figure 3a , right). Confocal microscopy also revealed that control green fluorescent protein (GFP) vector-transfected cells apparently underwent normal mitosis after release from nocodazole block. However, GFP-HSF1-transfected cells showed defective metaphase-anaphase transition and finally produced multinuclear cells (Figure 3b, upper) . Percentages of cells in prophase, metaphase and anaphase-telophase were examined after release from nocodazole block, and HSF1-transfected cells were observed to show 50% more cells in metaphase than pcDNA3 control vector-transfected cells at 2 h after release from nocodazole arrest (Figure 3b, bottom) . Moreover, we found that cyclin B1 and securin were degraded 150 min after nocodazole washout in pcDNA3 vector-transfected cells, and that HSF1 transfection inhibited this degradation (Figure 3c ). Stable HSF1 cell lines showed similar results (data not shown), though the expressions of spindle checkpoint proteins, for example, BubR1 and Mad2, and the binding activities of Cdc20 and Mad2 were unaffected by HSF1 transfection (Supplementary Figure 2) , which suggests that HSF1 does not affect mitotic checkpoint proteins.
Increase of aneuploidy and multinucleated cells by HSF1 overexpression When HA-tagged HSF1 was transiently transfected to RIF cells, aneuploidy (both 4N and >4N) was enhanced after 48 and 96 h of nocodazole treatment (Figure 4a, upper) . Confocal microscopy revealed that all GFP-HSF1-expressing cells formed multinucleated cells after 48 h of nocodazole treatment, whereas control vector-expressing cells, which did not show any fluorescence, did not (Figure 4a , bottom). When stable cell lines (nos. 2, 4 and 5) from RIF cells were established, HSF1-overexpressing cells were found to induce major HSPs, such as, HSP25 and inducible HP70, indicating that exogenous HSF1 activates the transcriptions of HSPs. In addition, aneuploidy in HSF1-overexpressing cells was represented by the production of >4N cells, and occurred without radiation or nocodazole treatment, but was increased further by irradiating cells (Supplementary Figure 3) . These findings indicate that HSF1 is involved in the development of aneuploidy and in the production of multinuclear cells. Since HSF1 is to be involved in the transcription of HSPs, we examined the involvements of HSP25 (or HSP27), and inducible HSP70 in HSF1-mediated aneuploidy production. Treatment of HSF1-overexpressing RIF cells with small RNAs that interfere with HSP25 or inducible HSP70 (Si-HSP25 or Si-HSP70) did not affect HSF1-mediated aneuploidy production (Supplementary Figure 4) . We found that Si-HSP70 inhibited the expressions of HSP25 and of inducible HSP70, which have been reported previously, that is, the downregulation of inducible HSP70 inhibited HSF1 activity by phosphorylating it at serine 307 and this also affected the expression of HSP25 (Seo et al., 2006) . Furthermore, when NCI-H358 cells, which express high levels of HSF1, were treated with Si-HSP27 or Si-HSP70, aneuploidy was not affected after 48 or 72 h of nocodazole treatment, indicating that HSP25 (or HSP27), and inducible HSP70 were not involved in the HSF1-mediated abnormal cell cycle distribution or in the production of aneuploidy. To elucidate whether an interaction between HSF1 and Cdc20 was responsible for aneuploidy production, various deletion mutants of HSF1 were transfected. The aneuploidy population was inhibited by HSF1DReg (Figure 4b, left) , suggesting that binding between HSF1 and Cdc20 is important for inhibiting mitotic exit and the development of aneuploidy. At 120 min after nocodazole release, transfections with either HSF1DReg or with HSP25 did not increase the stability of cyclin B1 or securin, whereas transfections with wild-type HSF1, HSF1DN or HSF1DC increased the stability of cyclin B1 and securin. Cdc2 kinase activity also appeared to correlate with cyclin B1 expression (Figure 4b, right) . Micronucleus analysis was used to test the hypothesis that aneuploidy production by HSF1 overexpression causes aberrations in genome inheritance. As shown in Figure 4c (left), HSF1-overexpressing cells had a greater number of micronuclei than control RIF cells. Since comparative genomic hybridization (CGH) arrays provide a means of comprehensively assessing genomic aberrations in detail, we carried out complete genomic profiling and frequency analyses. HSF1 overexpression was associated with increased losses and gain of chromosomes 1, 3, 6, 10, 11, 16 and 17 copy numbers in RIF cells as compared with control vector-transfected RIF cells (Figure 4c, right) .
HSF1-induced mitotic exit failure and genomic instability YJ Lee et al Cdc20 overexpression overcomes HSF1-mediated mitotic arrest and aneuploidy production When HSF1 or Cdc20 þ HSF1 were transfected into RIF cells, the Cdc20-HSF1 interaction was similar for HSF1 and for HSF1 þ Cdc20-transfected cells and the inhibition of Cdc27-Cdc20 binding by HSF1 was restored by Cdc20 cotransfection (Figure 5a ). In RIF cells stably expressing in HSF1 after additional Cdc20 transfection, inhibitions of the degradations of cyclin B1 and securin by HSF1 were also restored by additional transfection of Cdc20 (Figure 5b , left) and aneuploidy by HSF1 was also reduced (Figure 5b, right) . Transient cotransfection of HSF1 and Cdc20 also revealed that inhibitions of the degradations of cyclin B1 and securin by HSF1 were restored by Cdc20 cotransfection, and they reached the levels in control vector-cotransfected cells (Figure 5c , left) and nocodazole-mediated aneuploidy production by HSF1 was inhibited by Cdc20 cotransfection (Figure 5c , right). In addition, overexpression of Cdc20 to HOS or NCI-H1299 cells which showed high expression of HSF1 inhibited nocodazole-mediated aneuploidy production (Supplementary Figure 5) . These findings indicate that Cdc20 overexpression in HSF1 overexpressed cells can overcome HSF1-mediated mitotic arrest and aneuploidy cell production.
Endogenous overexpression of HSF1 is involved in mitotic arrest and aneuploidy production To elucidate the physiological relevance of HSF1-mediated aneuploidy production, HSF1 expression in normal and cancerous tissues, especially in lung cancer, was examined using a tissue array that consisted of lung tissues including squamous cell carcinoma, large cell carcinoma, small cell carcinoma and adenocarcinoma. HSF1, which was located in nucleus, was found to be (left) . Cell lysates at the indicated time after release from nocodazoleinduced arrest were immunoblotted using the indicated antibodies. Cdc2 kinase activities were determined using kinase assays. The y axis represents the fold induction of cyclin B1 and securin protein expressions when pcDNA control vector was 1 (right). (c) Micronuclei (per 500 binucleated cell) were counted in RIF cells stably transfected with control pcDNA3 or HSF1 vectors. Data are the means ± s.e.m. of three independent experiments. *Po0.05 (left). Changes in the genomic copy numbers of chromosomes were determined using CGH arrays in HSF1-overexpressing RIF cells (right). HSF1-induced mitotic exit failure and genomic instability YJ Lee et al HSF1 levels, that is, high HSF1 expression was associated with high aneuploidy (Figure 6b ). Moreover, treatment of HOS and NCI-H358 cells with small RNA for HSF1 (Si-HSF1) inhibited the Cdc20-HSF1 interaction and nocodazole-mediated aneuploid cell production (Figure 6c ), suggesting that the high expression of HSF1 in cancer cells might be involved in mitotic arrest and aneuploid cell production.
Discussion
In the present study, HSF1 that is frequently overexpressed in cancer cells was identified as a novel inhibitor of APC function. Specifically, HSF1 induced an aneuploidy population of cells by inhibiting mitotic exit, and this resulted from a direct interaction between HSF1 and Cdc20. Moreover, this interaction between HSF1 and Cdc20 inhibited Cdc20 to APC binding, which is necessary for the normal progression of metaphase to anaphase, and HSF1-mediated aneuploidy resulted in chromosome instability and the production of micronuclei. In the present study, HSF1 did not bind to Cdh1, another APC partner, suggesting the specific regulation of HSF1 in an APC-Cdc20 interaction pathway during mitotic progression. Mammals and chickens have evolved a family of HSFs (HSF1, HSF2 and HSF4 in mice and humans, and HSF1, HSF2 and HSF3 in chickens) that are differentially and specifically expressed during heatshock response, and it has been hypothesized that beyond heat-shock response mainly controlled by HSF1, each regulatory protein may impart specialized or unique properties in mammals (Pirkkala et al., 2001) . The binding sequence of HSF1 found to interact with Cdc20 constituted its regulatory domain (amino acids 212-320) (Figure 1 ). We did not find any sequence homology, when we compared this to those of HSF2 or HSF4. Indeed, when we attempted to immunoprecipitate HSF1, 2 and 4 with Cdc20, only HSF1 interacted with Cdc20, suggesting that interaction with Cdc20 and mitotic regulation is unique function of HSF1.
The best-characterized function of HSF1 is its stressactivated transcription factor action that controls HSP molecular chaperone expression (Ricaniadis et al., 2001) . RIF cells stably overexpressing HSF1 and NCI-H358 cells expressed high levels of HSPs and increased aneuploidy production. Interestingly, stably overexpressing HSF1 cells exhibited the high level of aneuploidy even without radiation or nocodazole treatment. Therefore, we examined whether HSF1-mediated aneuploidy is related to HSPs. However, we found that the knockdown of HSPs did not affect the aneuploidy production induced by HSF1 overexpression and regulatory domain deletion mutant of HSF1 that could not bind to Cdc20, did not affect the transcriptional activity of HSF1. Moreover, N-terminal and C-terminal deletion mutants of HSF1 did not affect HSF1-mediated aneuploidy (Figure 4) , suggesting that HSF1-mediated aneuploidy was not caused by an HSP alteration, but rather by a novel nontranscriptional function of HSF1 during cell cycle regulation. Wang et al. (2004) also suggested that dominant-negative HSF1 inhibited aneuploidy and this was associated with delayed breakdown of cyclin B1 by HSF1. Moreover, they hypothesized that HSF1-mediated increased stability of cyclin B1 and aneuploidy might be due to the increased induction of HSPs by HSF1, because HSPs were physically associated with the proteosome and therefore, might play a role in proteosomal activity like inhibition of cyclin B1 degradation. However, our data clearly demonstrated that HSF1-mediated aneuploidy and delayed cyclin B1 degradation were independent pathways of the transcriptional activity of HSF1.
The activity of APC-Cdc20 appears to be regulated in a partially cell cycle-dependent manner (Su et al., 1998) . In the present study, HSF1 was found to interact directly with Cdc20, and this interaction appeared to be responsible for aneuploidy production by HSF1, because transfection of a regulatory domain-deficient HSF1 mutant, which could not bind to Cdc20, also failed to produce aneuploidy in RIF cells (Figure 4 ). In addition, HSF1-overexpressing RIF cells showed inhibited Cdc27 phosphorylation, which was related to the increased stability of cyclin B1 and securin, and finally to the inhibition of mitotic exit and production of chromosomal instability (Figures 2 and 3 ) without alterations in mitotic checkpoint proteins like Mad2 and BubR1 (Supplementary Figure 5) . When sufficient Cdc20 was transfected into HSF1-overexpressing cells, aneuploidy production by HSF1 was inhibited and the degradations of cyclin B1 and securin were facilitated, that is, in HSF1-overexpressing cells, HSF1 binds predominantly to Cdc20, which inhibits the Cdc20-APC interaction, and the ubiquitination activity of APC that is responsible for cyclin B1 and securin degradation. Thus, when an excess of Cdc20 was added, APC bound to Cdc20 and thus restored the mitotic procedure (Figure 5 ), the stability of cyclin B1 and securin was restored to the control level and aneuploidy production was ceased.
This study shows that HSF1 regulates APC activation by directly binding with Cdc20, and suggests that HSF1 participates in the inhibition of mitotic exit and in aneuploidy. To the best of our knowledge, the information presented provides first evidence of HSF1-mediated chromosomal instability, independent of its transcriptional activity.
Materials and methods
Plasmid and constructs
Wild-type mouse HSF1 or HSF2 were cloned into pHACE containing a C-terminal HA tag and pFLAGN1 containing an N-terminal FLAG tag (Soh et al., 1999) . Internal deletion mutants were constructed in HSF1-containing pHACE vector by introducing two EcoRI sites into the HSF1 coding sequence using deletion primers. PCR products were also cloned into pEGFP-N1 vector (BD Biosciences Clontech, Bedford, MA)
